Doxazosin
Doxanorm belongs to a group of medicines called alpha-adrenergic blockers. It works by dilating blood vessels, reducing peripheral resistance, which leads to a decrease in blood pressure.
Doxanorm is also an antagonist of alpha-adrenergic receptors in the prostate and bladder. It reduces symptoms associated with difficulty in urinating and improves urodynamic test results (related to urine flow).
Doxanorm is indicated for the treatment of:
Doxanorm is contraindicated in monotherapy in patients with overflow incontinence, anuria without progressive renal failure, or with it.
Before starting treatment with Doxanorm, discuss it with your doctor or pharmacist.
Use in patients undergoing cataract surgery
During cataract surgery in some patients taking Doxanorm currently or previously, "intraoperative floppy iris syndrome" (a variant of small pupil syndrome) has been observed. Inform your ophthalmologist about taking alpha-adrenergic blockers before surgery.
Consult a doctor, even if the above warnings refer to situations that have occurred in the past.
Doxanorm is not recommended for use in children and adolescents under 18 years of age, as its safety and efficacy have not been established in this age group.
Tell your doctor about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
The blood pressure-lowering effect of doxazosin may be enhanced by:
The blood pressure-lowering effect of doxazosin may be weakened by:
Doxazosin may weaken the effect of dopamine, ephedrine, epinephrine, metaraminol, methoxamine, and phenylephrine on blood pressure, as well as on blood vessels. Since there are no data on interactions with liver metabolism-affecting medicines (e.g., cimetidine), caution is advised when administering these medicines with doxazosin.
In vitro studies have shown that doxazosin does not affect the binding of digoxin, warfarin, phenytoin, or indomethacin to plasma proteins.
During clinical trials with doxazosin, no interactions were found with thiazide diuretics, furosemide, beta-adrenergic blockers, non-steroidal anti-inflammatory drugs, antibiotics, oral hypoglycemic agents (used in diabetes), uricosuric agents, and anticoagulants.
Doxazosin may increase plasma renin activity and vanillylmandelic acid excretion in urine. This should be taken into account when interpreting laboratory test results.
Doxazosin enhances the blood pressure-lowering effect of other alpha-adrenergic blockers and other antihypertensive medicines.
Clinical trials have shown that doxazosin has a beneficial effect on lipids, significantly reducing total triglyceride, total cholesterol, and LDL fraction levels in plasma. Doxanorm treatment has a beneficial effect on hypertension and lipid levels, resulting in a reduced risk of coronary artery disease.
Some patients taking alpha-adrenergic blockers for hypertension or prostate enlargement may experience dizziness or a feeling of emptiness in the head, which may be caused by a sudden drop in blood pressure when changing body position while sitting or standing. Some patients have experienced these symptoms when taking alpha-adrenergic blockers with medicines used for erectile dysfunction (impotence). To minimize the risk of these symptoms, it is recommended to take daily doses of alpha-adrenergic blockers regularly before starting treatment with medicines for erectile dysfunction.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medicine.
The use of Doxanorm has not been evaluated in pregnant women.
Doxanorm is contraindicated during breastfeeding.
Your doctor will decide whether to stop breastfeeding or discontinue the medicine.
Given individual reactions to doxazosin, the ability to perform activities such as driving vehicles and operating machines, or performing specific types of work that require maintaining balance, may be impaired, especially at the beginning of treatment, after dose increase, switching to another medicine, or when consuming alcohol.
If you have been diagnosed with intolerance to some sugars, consult your doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".
Always take this medicine exactly as your doctor has told you.
In case of doubts, consult a doctor or pharmacist.
Essential hypertension
The initial dose is 1 mg once daily. Depending on efficacy, after 1-2 weeks, the doctor may increase the dose to 2 mg of doxazosin once daily, then to 4 mg of doxazosin once daily, and finally to 8 mg of doxazosin once daily. The average maintenance dose is between 2 and 4 mg of doxazosin once daily.
The maximum recommended dose is 16 mg of doxazosin per day.
To start treatment, the following dosing schedule is recommended:
day 1-8: 1 mg of doxazosin in the morning
day 9-14: 2 mg of doxazosin in the morning
Then, the dose can be increased to the effective maintenance dose.
Benign prostatic hyperplasia (BPH)
The initial dose is 1 mg once daily. If necessary, after 1-2 weeks, the doctor may increase the dose to 2 mg of doxazosin once daily, and then to 4 mg of doxazosin once daily.
The maximum recommended dose is 8 mg of doxazosin per day.
To start treatment, the following dosing schedule is recommended:
day 1-8: 1 mg of doxazosin once daily
day 9-14: 2 mg of doxazosin once daily
Then, the dose can be increased individually to the effective maintenance dose.
Oral administration.
Swallow the tablets whole with water. The duration of treatment is determined by the doctor.
Doxanorm is not recommended for use in children and adolescents under 18 years of age.
Elderly patients
There is no need to adjust the dose in elderly patients. However, the dose should be as low as possible, and any dose increase should be done under close medical supervision.
Patients with liver function disorders
Caution is advised. There is no clinical experience with the use of the medicine in patients with severe liver dysfunction.
Patients with kidney function disorders
There is no need to adjust the dose in patients with kidney function disorders. However, the dose should be as low as possible, and any dose increase should be done under close medical supervision.
In case of overdose, hypotension may occur.
If a higher dose of Doxanorm is taken than recommended, consult a doctor.
Depending on the symptoms, the doctor will administer the appropriate treatment. Since doxazosin is 98% bound to plasma proteins, dialysis is not a recommended treatment for overdose.
If you forget to take a dose of Doxanorm, take it as soon as possible, unless it is almost time for the next dose. In this case, take the next dose at the scheduled time. Do not take a double dose to make up for the missed dose.
In case of any further doubts about taking this medicine, consult a doctor or pharmacist.
Like all medicines, Doxanorm can cause side effects, although not everybody gets them.
The following side effects may occur when taking this medicine:
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect less than 1 in 1,000 people)
Side effects with unknown frequency (cannot be estimated from available data)
If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, phone: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of this medicine.
Store in a temperature below 30°C.
Store in a place out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Doxanorm is available as tablets.
The packaging (carton box) contains 3 blisters of 10 tablets each (30 tablets).
Bausch Health Ireland Limited
3013 Lake Drive
Citywest Business Campus
Dublin 24, D24PPT3
Ireland
ICN Polfa Rzeszów S.A.
ul. Przemysłowa 2
35-959 Rzeszów
Bausch Health Poland sp. z o.o.
ul. Przemysłowa 2
35-959 Rzeszów
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.